search
biomedical research
Trends
- 1Cornell Course BME 4440 Takes Biomedical Research Into Policy▼Science and Policy in Action: How BME 4440 Brings Research Beyond the Classroom
The Cornell Daily Sun reports on BME 4440, a biomedical engineering course at Cornell University that pushes students to carry their research beyond the classroom and into science policy. The course is framed as an example of how academic work can inform decision-making, connecting technical training with real-world policy applications.
- 2UChicago Medicine Names Josh Denny to Senior Precision Medicine Role▼UChicago Medicine Appoints National Precision Medicine Leader Josh Denny to New Senior Leadership Role | Newswise
UChicago Medicine has appointed Josh Denny, a national leader in precision medicine, to a new senior leadership position. Denny is known for his work in genomics and large-scale biomedical research, and his arrival signals the academic health system's intent to expand precision medicine efforts. Details about his exact title and start date were not included in the announcement.
- 3Wayne State PhD student wins NIH grant for Down syndrome leukemia research▼Wayne State doctoral student receives NIH support for research into childhood leukemia associated with Down syndrome
A Wayne State University doctoral student has received support from the National Institutes of Health to fund research into childhood leukemia associated with Down syndrome. Children with Down syndrome face a significantly higher risk of developing leukemia, and the NIH funding will help advance studies aimed at understanding and potentially treating the disease. The award highlights Wayne State's growing biomedical research profile.
- 4Napoleone Ferrara Wins 2026 Yergin Family Biomedical Research Prize▼Napoleone Ferrara, MD, Receives 2026 Yergin Family International Prize for Biomedical Research
Napoleone Ferrara, MD, has been awarded the 2026 Yergin Family International Prize for Biomedical Research. Ferrara is best known for his work on vascular endothelial growth factor (VEGF), which led to major anti-angiogenic therapies for cancer and eye disease. The announcement was made by the Icahn School of Medicine at Mount Sinai, which hosts the prize. Further details about the award ceremony and the prize committee's reasoning were not immediately available.
- 5
With the incoming administration and Congress signaling closer scrutiny of federal research spending, backers are preparing a lame-duck push to shield National Institutes of Health grantmaking from political interference. The effort aims to lock in protections for how NIH awards biomedical research grants before power shifts in Washington. Details of the legislative vehicle and its prospects remain unclear.
- 6
MIT researchers have developed an aquatic robot driven by living muscle tissue, combining engineered materials with biological cells to power underwater movement. The work points to new possibilities for soft robotics and biomedical applications, and is drawing attention for its blend of synthetic and living components.
- 7Qurient's CDK7 Inhibitor Q901 Shows Synergy with ADCs in Science Advances▼Qurient Announces Publication in Science Advances Demonstrating Synergistic Effect of Selective CDK7 Inhibitor Q901 with TOP1 Inhibitor-Based ADCs
South Korean biotech Qurient announced that its research has been published in Science Advances, showing that its selective CDK7 inhibitor Q901 works synergistically with TOP1 inhibitor-based antibody-drug conjugates. The finding supports combining Q901 with established cancer treatments and may strengthen the company's position in oncology drug development, drawing attention from investors and the biomedical research community.
- 8AI-powered chip detects tumor cells in blood without labels●Label-free microfluidic chip and AI identify blood-borne tumor cells
Researchers have developed a label-free microfluidic chip paired with artificial intelligence that can identify circulating tumor cells in blood samples. The approach detects cancer cells directly without chemical labels, potentially enabling faster, less invasive cancer diagnostics. The advance is being reported in medical and biotechnology news as a promising step for liquid biopsy and early cancer detection.